Skye Bioscience, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Schwab Andrew J. | — | Sale | 2,314 | $3.57 | $8,261 | 63,963 | Aug 22, 2025 |
| ROCKLAGE SCOTT M | — | Sale | 2,314 | $3.57 | $8,261 | 63,963 | Aug 21, 2025 |
| DHILLON PUNIT | Chief Executive Officer | Sale | 364 | $5.55 | $2,020 | 412,369 | Nov 18, 2024 |
| Grayson Paul A. | — | Sale | 307 | $5.55 | $1,704 | 345,945 | Nov 18, 2024 |
| ARSENAULT KAITLYN | Chief Financial Officer | Sale | 43,026 | $4.99 | $214,700 | 167,522 | Nov 15, 2024 |
| Diep Tuan Tu | Chief Development Officer | Sale | 19,489 | $4.99 | $97,250 | 82,259 | Nov 15, 2024 |
| ARSENAULT KAITLYN | Chief Financial Officer | Sale | 43,206 | $4.99 | $215,598 | 166,342 | Nov 15, 2024 |
| Schwab Andrew J. | — | Sale | 1,440 | $6.60 | $9,504 | 66,356 | Sep 13, 2024 |
| 5AM Ventures VII, L.P. | — | Sale | 79 | $6.06 | $479 | 66,277 | Sep 11, 2024 |
| DHILLON PUNIT | Chief Executive Officer | Other | 15,727 | — | — | 412,733 | Aug 26, 2024 |
| PARMAR KUSH | — | Purchase | 450,000 | $10.00 | $4,500,000 | 8,393,520 | Mar 13, 2024 |
| Schwab Andrew J. | — | Award / Grant | 450,000 | $10.00 | $4,500,000 | 8,393,520 | Mar 13, 2024 |
| Grayson Paul A. | — | Award / Grant | 100,000 | — | — | 346,252 | Feb 29, 2024 |
| Diep Tuan Tu | Chief Development Officer | Award / Grant | 25,000 | — | — | 101,833 | Feb 29, 2024 |
| ARSENAULT KAITLYN | Chief Financial Officer | Award / Grant | 25,000 | — | — | 209,738 | Feb 29, 2024 |
| DHILLON PUNIT | Chief Executive Officer | Award / Grant | 100,000 | — | — | 397,006 | Feb 29, 2024 |
| ARSENAULT KAITLYN | Chief Financial Officer | Award / Grant | 25,000 | — | — | 210,738 | Feb 29, 2024 |
| DHILLON PUNIT | Chief Executive Officer | Award / Grant | 100,000 | — | — | 397,006 | Feb 29, 2024 |
| Schwab Andrew J. | — | Award / Grant | 5,206,074 | $2.31 | $12,026,031 | 7,943,520 | Jan 31, 2024 |
| DIEKMAN JOHN D | — | Purchase | 5,206,074 | $2.31 | $12,026,031 | 7,943,520 | Jan 31, 2024 |
| ARSENAULT KAITLYN | Chief Financial Officer | Award / Grant | 128,209 | — | — | 185,738 | Nov 6, 2023 |
| DHILLON PUNIT | Chief Executive Officer | Award / Grant | 194,270 | — | — | 297,006 | Nov 6, 2023 |
| Grayson Paul A. | — | Award / Grant | 173,721 | — | — | 246,252 | Nov 6, 2023 |
| DHILLON PUNIT | Chief Executive Officer | L | 110,000 | $0.02 | $2,200 | 40,673,828 | Aug 29, 2023 |
| DHILLON PUNIT | Chief Executive Officer | Award / Grant | 20,277,414 | — | — | 24,683,957 | Aug 28, 2023 |
| Grayson Paul A. | — | Award / Grant | 18,132,596 | — | — | 18,132,596 | Aug 25, 2023 |
| ARSENAULT KAITLYN | Chief Financial Officer | Award / Grant | 13,382,118 | — | — | 14,382,118 | Aug 25, 2023 |
| Schwab Andrew J. | — | Award / Grant | 267,602,039 | — | — | 267,602,039 | Aug 18, 2023 |
| Emerald Health Sciences Inc. | — | Award / Grant | 41,379,164 | $0.04 | $1,655,167 | 169,407,901 | Feb 22, 2023 |
| DHILLON PUNIT | Chief Executive Officer | Award / Grant | 1,406,543 | — | — | 4,406,543 | Nov 10, 2022 |
| Rai Sukhwinder Singh | — | Award / Grant | 73,561 | — | — | 73,561 | Nov 10, 2022 |
| DHILLON PUNIT | Chief Executive Officer | Award / Grant | 2,000,000 | — | — | 3,000,000 | Dec 14, 2021 |
| Arsenault Kaitlyn Melanie | Chief Financial Officer | Award / Grant | 1,000,000 | — | — | 1,000,000 | Dec 14, 2021 |
| Emerald Health Sciences Inc. | — | Sale | 2,566,666 | $0.10 | $256,667 | 111,387,251 | Aug 7, 2020 |
| Emerald Health Sciences Inc. | — | Sale | 2,566,666 | $0.10 | $256,667 | 123,923,501 | Aug 7, 2020 |
| Emerald Health Sciences Inc. | — | Sale | 3,000,000 | $0.10 | $300,000 | 123,490,167 | Aug 7, 2020 |
| DHILLON PUNIT | CEO | Purchase | 1,000,000 | $100,000.00 | $100,000,000,000 | 1,000,000 | Aug 7, 2020 |
| HEPPELL JAMES L | — | Purchase | 500,000 | $50,000.00 | $25,000,000,000 | 500,000 | Aug 7, 2020 |
| Emerald Health Sciences Inc. | — | Other | 40,800,000 | $4,080,000.00 | $166,464,000,000,000 | 126,490,167 | Dec 20, 2019 |
| Emerald Health Sciences Inc. | — | Other | 37,667 | — | — | 73,153,917 | Dec 27, 2018 |
| Cesario Douglas A | CFO and Secretary | Award / Grant | 643,501 | — | — | 643,501 | Jul 23, 2018 |
| Emerald Health Sciences Inc. | — | C | 12,335,000 | $0.10 | $1,233,500 | 53,116,250 | Mar 29, 2018 |
| Emerald Health Sciences Inc. | — | Purchase | 15,000,000 | — | — | 39,000,000 | Feb 16, 2018 |
| Emerald Health Sciences Inc. | — | X | 1,781,250 | — | — | 40,781,250 | Jan 24, 2018 |
| Berecz Elizabeth | Chief Financial Officer | Award / Grant | 700,000 | — | — | 1,050,000 | Jan 18, 2018 |
| LYKOS COSMAS N | Chairman | Award / Grant | 900,000 | — | — | 4,599,400 | Jan 18, 2018 |
| Murphy Brian Stuart | CEO, Chief Medical Officer | Award / Grant | 900,000 | — | — | 1,275,000 | Jan 18, 2018 |
| Lapham Reg Alexander | — | X | 119,700 | $1.00 | $119,700 | 3,787,500 | Mar 13, 2017 |
| Murphy Brian Stuart | CEO, Chief Medical Officer | Award / Grant | 375,000 | — | — | 375,000 | Oct 20, 2015 |
| Berecz Elizabeth | Chief Financial Officer | Award / Grant | 350,000 | — | — | 350,000 | Oct 20, 2015 |